Galena Biopharma, Inc. (GALE) Stock Moves Down and Here’s Why

Galena Biopharma, Inc. (NASDAQ: GALE) shares fell on Thursday February 2 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.

Meanwhile, The Dow Jones Industrial Average DJIA, -0.10% fell 34 points, or 0.2%, to 19,858. The S&P 500 SPX, -0.11% lost 4 points to 2,276, a drop of 0.2%. The Nasdaq Composite Index COMP, -0.05% slid 16 points, or 0.3%, to 5,626. Among the most actively traded Nasdaq stocks was Facebook Inc FB, +0.31% which fell 0.7% a day after it reported its quarterly results.

Shares of Galena Biopharma, Inc. (NASDAQ: GALE) were downgraded by analysts at Maxim Group in a note to their investors today. Maxim Group currently has a rating of Hold on the shares. The one-year price target of $7.67 is higher than the opening price of $1.29, resulting a fair amount of other analysts to report on the company recently. Looking back over the last year, Galena Biopharma, Inc. stock has a high of $49.80. Downgrades occur when analysts feel that the future prospects for the security have dropped from the original recommendation, usually caused by a material and fundamental digression in the company’s operations, future vision or industry.

Shares of Galena Biopharma, Inc. (NASDAQ: GALE) opened at $1.29 yesterday and traded in a range between, $1.15 and $1.33, and last traded at $1.16, which is a drop of $0.12 compared to the previous closing price.

Galena Biopharma, Inc. (NASDAQ: GALE) currently has a market cap of 12.59M.

Galena Biopharma, Inc. (NASDAQ: GALE) Average Daily Trading Volume

354,717 shares traded hands yesterday, 108 percent lower than the average, out of a total float 9,370,000. lower than normal. Look for trading volume to pick up in the coming days as swing traders often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for one day will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these have substantial teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

Galena Biopharma, Inc. (NASDAQ: GALE) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

Trades for Galena Biopharma, Inc. (NASDAQ: GALE) have ranged from $1.15 – 49.80, and the stock now has a 50-day MA of $1.92 and 200-day MA of $1.14. Today’s last price is 97.67%% under the 52 week high of $49.80.

Earnings growth is an important factor to consider when investing in stocks and investors seek companies that have been successful at growing their earnings at least 25% or more for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply